Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer

Journal of the National Cancer Institute

Volumn 90, Issue 7, 1998, Pages 512-518

  Helzlsouer, Kathy J ^a   Selmin, Ornella ^b,c   Huang, Han Yao ^a   Strickland, Paul T ^a   Hoffman, Sandra ^a   Alberg, Anthony J ^a   Watson, Mary ^b   Comstock, George W ^a   Bell, Douglas ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY;

EID: 0032054961     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.7.512     Document Type: Article

References (35)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking, N-acetyltansferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
2. Ketterer B. The protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988;202: 343-61.
3. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
4. Wiencke JK, Pemble S. Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995;4: 253-9.
5. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, et al. The human glutathione S-transferases: a case-control study of the incidence of the GST1 theta phenotype in patients with adenocarcinoma. Carcinogenesis 1991;12:25-8.
6. Russo D, Marie JP, Zhou DC, Faussat AM, Delmer A, Maisonneuve L, et al. Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdrl) genes in acute myeloid and lymphoid leukemias. Leukemia 1994;8:881-4.
7. Seidegard J, DePierre JW, Pero RW. Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbene oxide in resting human mononuclear leukocytes are due to a particular isozyme(s). Carcinogenesis 1985;6:1211-6.
8. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85: 7293-7.
9. Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, et al. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect 1992;98:113-7.
10. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
11. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 1990;11:33-6.
12. Ambrosone CB. Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-5.
13. Kelsey KT, Hankinson SE, Colditz GA, Springer K, Garcia-Closas M, Spiegelman D, et al. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev 1997;6:511-5.
14. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53(10 Suppl):2312-8.
15. Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, et al. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta 1995;240:53-61.
16. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996;17:881-4.
17. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, et al. Increased risk for myelodysplastic syndromes among those with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996;347:295-7.
18. Board PG, Webb GC, Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 1989;53:205-13.
19. Zimniak P, Nandur B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893-9.
20. Watson MA, Stewart R, Smith G, Massey TE, Bell DA. Glutathione S-transferase P1 polymorphism. Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. In press.
21. Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993;11:49-58.
22. Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol 1995; 26:1221-6.
23. Russo D, Marie JP, Zhou DC, Faussat AM, Delmer A, Maisonneuve L, et al. Coexpression of anionic glutathione S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias. Leukemia 1994;8:881-4.
24. Harries LW, Stubbins MJ, Forman G, Howard GC, Wolf CR, Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4.
25. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9.
26. Final Maryland Cancer Registry (MCR) Data Report, Northwest Region, 1993. Maryland Cancer Registry. Bel Air (MD): Tri-Analytics, Inc., 1993.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
28. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory, 1982:458-9.
29. Dunnick JK, Elwell MR, Huff J, Barrett JC. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis 1995;16: 173-9.
30. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996;56:287-93.
31. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, et al. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 1995;4:233-8.
32. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-4.
33. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-32.
34. Byers T. Nutritional risk factors for breast cancer. Cancer 1994;74(1 Suppl):288-95.
35. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57: 5493-7.